Apoptosis inducer 25
Apoptosis inducer 25 (Compound 4H) inhibits the proliferation of cell BGC-823 with IC50 of 0.37 μM. Apoptosis inducer 25 arrests cell cycle at G2/M phase, induces apoptosis in cell BGC-823, and causes mitochondrial dysfunction. Apoptosis inducer 25 exhibits good pharmacokinetic properties in rats[1].
Product Specifications
CAS Number
2763063-15-4
UNSPSC
12352005
Target
Apoptosis
Type
Reference compound
Related Pathways
Apoptosis
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/apoptosis-inducer-25.html
Smiles
O=C1C(C#N)=C[C@]2([C@]([H])(C1(C)C)CC[C@](C)(C2=CC3=O)[C@]4([C@]3([C@]5([C@@](C(OCCCCOC(C6=CC=C(C=C6)O)=O)=O)(CC4)CCC(C)(C5)C)[H])[H])C)C
Molecular Formula
C42H53NO7
Molecular Weight
683.87
References & Citations
[1]Li N, et al., New CDDO Arylboronate Ester Derivatives with High Selectivity and Low Toxicity. J Med Chem. 2024 Aug 22;67 (16) :14329-14344.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Pmel17 / gp100 / SILV (NKI-beteb), CF568 conjugate, 0.1mg/mL
TYRP1 (Tyrosinase Related Protein 1) (TA99), CF405S conjugate, 0.1mg/mL
Mucin 5AC (MUC5AC) (45M1), CF568 conjugate, 0.1mg/mL
Ep-CAM / CD326 (Extracellular Domain) (Epithelial Marker) (EGP40/1798), CF488A conjugate, 0.1mg/mL
C1QA / Complement C1q A-Chain (C1QA/2953), CF647 conjugate, 0.1mg/mL
